Health Care Select Sector SPDR Fund

Health Care Select Sector SPDR Fund (XLV) ETF Price, Holdings & Analysis

ETFNYSE ArcaSector

Price

168.8 USD

-0.64%

Price history

Over the past year XLV traded between 134.13 USD and 175.68 USD, closing at 168.8 USD on Sep 24, 2026.

Key statistics

Fund assets43.91B USD
P/E ratio (TTM)30.2
Dividend yield1.07%
Annual dividend1.81 USD
52-week range133.73 – 176.6
Volume7,327,832
Average volume9,138,322
Fund familyState Street Investment Management
Inception dateDec 16, 1998
NAV168.96 USD
ISINUS81369Y2090
ExchangeNYSEArca

Top holdings

Eli Lilly and Co14.87%
Johnson & Johnson10.4%
AbbVie Inc7.36%
Merck & Co Inc5.93%
UnitedHealth Group Inc5.75%
Amgen Inc3.77%
Thermo Fisher Scientific Inc3.73%
Abbott Laboratories3.12%
Gilead Sciences Inc2.95%
Pfizer Inc2.64%

Sector weights

  • healthcare100%

Overview

What XLV does

Health Care Select Sector SPDR Fund (symbol XLV) is an ETF that tracks the Health Care sector within the S&P 500. It is part of the State Street Investment Management family and invests exclusively in healthcare companies listed on the NYSE Arca. The fund aims to reflect the performance of the health care sector, with 100% of its weight in that sector.

Key numbers explained

  • Price: The current market price of one share of XLV is 168.8 USD. This is the latest trading price on the exchange.
  • Price change today: The share price moved -0.64% during today's session, indicating a slight intraday decline.
  • Trailing P/E ratio: The P/E ratio of 30.2 shows how much investors pay per dollar of the fund's trailing earnings. A higher P/E can reflect higher growth expectations or richer valuations.
  • Dividend yield: The dividend yield of 1.07% represents the annual dividend payment as a percentage of the current share price. It is a way to compare income generated by the fund relative to its price.
  • 52-week range: Over the past year, XLV traded between a low of 133.73 and a high of 176.6, showing the price spread during that period.
  • Fund assets: The fund manages 43.91B USD in total assets, which reflects its size and liquidity in the market.
  • Top holdings: The largest positions are Eli Lilly and Co (14.9%), Johnson & Johnson (10.4%), AbbVie Inc (7.4%), Merck & Co Inc (5.9%), and UnitedHealth Group Inc (5.8%).
  • Fund inception: The fund was launched on Dec 16, 1998, giving it a long track record.

Recent news

Recent headlines indicate that healthcare stocks have experienced some pressure, with a late-afternoon retreat noted in sector updates. Separate reports mention declines in specific healthcare-related stocks such as Ocular Therapeutix, ANI Pharmaceuticals, Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes. Broader market coverage also highlights potential tech-sector headwinds heading into the midterm elections, which can affect investor sentiment across sectors including healthcare.

What to watch

Investors tracking XLV often monitor the performance of its largest holdings, such as Eli Lilly and Johnson & Johnson, as their results can move the fund. Sector-specific factors like regulatory changes, drug pricing policy, and healthcare legislation can influence the health care sector broadly. Comparing XLV with peers like the Financial Select Sector SPDR Fund (XLF) or the Energy Select Sector SPDR Fund (XLE) can help contextualise its sector allocation. For those interested in technology exposure, alternatives such as the Technology Select Sector SPDR Fund (XLK) or the iShares S&P 500 Information Technology Sector UCITS ETF (IUIT) offer different sector tilts.

FAQ

Q: Does XLV pay a dividend? A: Yes, the fund has a dividend yield of 1.07%, which reflects the annual dividend income relative to its share price.

Q: What is the XLV P/E ratio? A: The trailing P/E ratio is 30.2, indicating the price paid per dollar of trailing earnings.

Q: Where can I buy XLV? A: XLV trades on the NYSE Arca exchange under the symbol XLV.

Q: What is the fund family of XLV? A: The fund is managed by State Street Investment Management.

Q: When was XLV launched? A: The fund was launched on Dec 16, 1998.

Q: What are the top holdings of XLV? A: The top holdings include Eli Lilly and Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, and UnitedHealth Group Inc.

Latest news & filings

Frequently asked questions

Does XLV pay a dividend?

Yes, the fund has a dividend yield of 1.07%, which reflects the annual dividend income relative to its share price.

What is the XLV P/E ratio?

The trailing P/E ratio is 30.2, indicating the price paid per dollar of trailing earnings.

Where can I buy XLV?

XLV trades on the NYSE Arca exchange under the symbol XLV.

What is the fund family of XLV?

The fund is managed by State Street Investment Management.

When was XLV launched?

The fund was launched on Dec 16, 1998.

What are the top holdings of XLV?

The top holdings include Eli Lilly and Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, and UnitedHealth Group Inc.

Track XLV in your portfolio

Hold XLV at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.

Start free

Data as of Sep 23, 2026. Sources: Yahoo Finance, Bucharest Stock Exchange.

For information and education only — not investment advice. Prices may be delayed. The overview is generated with AI from the data shown on this page.